Shrimp Disease Diagnostics Market Size, Share, Growth, and Industry Growth By Type (WSSV, TSV, YHV/GAV, IHHNV, HPV, MBV (Monodon Baculo virus), IMNV (Infectious Myonecrosis Virus), NHP-B (Necrotising Hepatopancreatitis Bacteria and others) By Application (fisherise, aquaculature laboratories, education and research institute and others) regional forecast From 2025 To 2033
Trending Insights

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels
-
Request a Free sample to learn more about this report
SHRIMP DISEASE DIAGNOSTICS MARKET OVERVIEW
The global Shrimp Disease Diagnostics Market was valued at USD 0.147 billion in 2024 and is expected to rise to USD 0.16 billion in 2025, eventually reaching USD 0.4 billion by 2033, expanding at a CAGR of 11.82% from 2025 to 2033.
Shrimp disease diagnostics is a technology that helps to detect shrimp suffering from any sort of virus.
Increased demand for shrimp for human consumption coupled with growing demand for marine & freshwater farming is the major factor of the market growth. The growing popularity of aqua food habits is predicted to drive market growth. Increased awareness about the consumption of shrimp and demand for high nutrition diet is expected to fuel market growth in the forthcoming years. Further, a rise in awareness of diseases associated with shrimp and digestion problems is anticipated to foster market progress. The growing need for DNA-based diagnostic tools such as PCR and the rapid adoption of technology in the marine and aqua sectors is projected to expand market growth. In addition, the easy availability of test kits in the pharmaceutical is expected to drive market growth. On the contrary, the high cost associated with disease diagnostic technology is predicted to restrict market growth in the forthcoming years.
COVID-19 IMPACT
Lack of Fishermen due to Lockdown Restrictions to Harm Market Growth
Closure of manufacturing units and lower demand for the technology due to lockdown restrictions. The shutdown of marine and aquaculture laboratories and the lack of fishers due to health safety restrict the market growth.
LATEST TRENDS
Increased Demand for Seafood Globally to Push Market Growth
Increasing demand for seafood globally is estimated to fuel market growth. A rise in awareness about the benefits of seafood in diet coupled with a high need for a nutritious diet is predicted to surge market growth. Huge demand for protein-based dirt for muscle gain and an increased number of dietitians refer to seafood for high protein and other several nutritional properties. These factors are estimated to boost technology adoption in the forthcoming years. The growing popularity of aqua food habits is predicted to drive market growth. Increased awareness about the consumption of shrimp and demand for high nutrition diet is expected to fuel shrimp diseases diagnostics market market growth.
SHRIMP DISEASE DIAGNOSTICS MARKET SEGMENTATION
By Type
Based on type, the market is divided into IHHNV (Infectious Hypodermal and Hematopoietic Virus), MBV (Monodon Baculovirus), WSSV (White Spot Syndrome Virus), HPV (Hepatopancreatic Parvovirus), NHP-B (Necrotising Hepatopancreatitis Bacteria), TSV (Taura Syndrome Virus), YHV/GAV (Yellow Head/Gill, Associated Virus), IMNV (Infectious Myonecrosis Virus), MOV (Mourilyan Virus), and Early Mortality Syndrome (EMS).
WSSV (White Spot Syndrome Virus) is expected to be the top part of the segmentation type.
By Application
Based on the application, the market is divided into fisheries, aquaculture laboratories, marine laboratories, education and research institutes, and others.
Aquaculture laboratories are expected to be the top part of application segmentation.
DRIVING FACTORS
Growing need for Shrimp Farming and Huge Production of Shrimps to Surge Market Growth
Increasing demand for shrimp globally and huge production of shrimp are anticipated to drive market growth. A rise in demand for technology in education and research institutes is projected to contribute to market growth. Increased need to reduce disease prevalence and huge adoption of technology is predicted to surge market growth. Increased spending capacity and growing awareness about health safety are anticipated to accelerate market progress in the forthcoming years. Increased demand for freshwater and marine shrimp farming is expected to fuel market progress.
Increased Prevalence of Viral Infections in Shrimps to Foster Market Progress
The growing prevalence of viral infection in shrimps and the high need to detect to control spreading is estimated to fuel market growth. Huge demand to detect shrimp disease and a growing need to improve marine farming methods is anticipated to drive market growth. An increased number of manufacturers are focused on developing PCR base systems and ensuring flexible & real is estimated to drive market growth in the forthcoming years.
RESTRAINING FACTORS
High Cost of the Technology to Harm Market Progress
The high cost associated with disease diagnostic technology is predicted to restrict market growth in the forthcoming years.
-
Request a Free sample to learn more about this report
SHRIMP DISEASE DIAGNOSTICS MARKET REGIONAL INSIGHTS
High Production Rate in Asia Pacific to Drive Market Share
Asia Pacific is anticipated to dominate the shrimp disease diagnostics market share owing to the high production rate in India and China. Increased government regulation for food safety and huge consumption of shrimp’s consumption. The growing popularity of aqua food habits is predicted to drive market growth. Increased awareness about the consumption of shrimp and demand for high nutrition diet is expected to fuel market growth in the forthcoming years. Further, a rise in awareness of diseases associated with shrimp and digestion problems is anticipated to foster market progress. The growing need for DNA-based diagnostic tools such as PCR and the rapid adoption of technology in the marine and aqua sectors is projected to expand market growth.
KEY INDUSTRY PLAYERS
Leading Players Adopt New Strategies to Stay Competitive
The report covers information about the list of market players and their latest development in the industry. The information includes mergers, partnerships, acquisitions, technological developments, and production lines. Other aspects examined for this market include complete research on companies producing and introducing the latest products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.
List of Top Shrimp Disease Diagnostics Companies
- GeneReach Biotechnology Corp. (China)
- REAGEN LLC (U.S.)
- Auro Biotechnologies (India)
- HiMedia Laboratories (India)
- pop bio (U.K.)
- AquaBounty Technologies, Inc. (U.S.)
- Lab - Ind Resource Sdn Bhd. (Malaysia)
- FUJIKURA KASEI CO., LTD. (Japan)
- Thermo Fisher Scientific (U.S.)
- SUREBIO (U.S.)
- Speedy Assay Sdn Bhd (Malaysia)
REPORT COVERAGE
This research profiles a report with general studies that explain the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by examining the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, and others. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.
Attributes | Details |
---|---|
Market Size Value In |
US$ 0.14 Billion in 2024 |
Market Size Value By |
US$ 0.5 Billion by 2033 |
Growth Rate |
CAGR of 11.82% from 2024 to 2033 |
Forecast Period |
2025to2033 |
Base Year |
2024 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
|
By Type
|
|
By Application
|
FAQs
The global shrimp disease diagnostics market size is expected to reach USD 0.5 billion in 2032.
The shrimp disease diagnostics market is expected to exhibit a CAGR of 14.35% by 2032.
Drivers of this shrimp disease diagnostics market are growing need for shrimp farming and huge production of shrimps and the increased prevalence of viral infections in shrimps.
GeneReach Biotechnology Corp., REAGEN LLC, Auro Biotechnologies, HiMedia Laboratories pop bio, AquaBounty Technologies, Inc., Lab - Ind Resource Sdn Bhd., FUJIKURA KASEI CO., LTD., Thermo Fisher Scientific, SUREBIO, and Speedy Assay Sdn Bhd are the top companies operating in the shrimp disease diagnostics market.